Skip to main content
Log in

Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Cranial MRI was used to study treatment-related changes in children undergoing therapy for acute lymphoblastic leukaemia (ALL) or lymphoma. Nineteen children (18 with ALL, 1 with lymphoma) underwent MRI at the beginning of treatment and at intervals during it, to a total of 105 imaging studies and a minimum of 3 per case. Nine patients had finished all therapy, all received consolidation treatment. No patient had central nervous system (CNS) leukaemia at diagnosis or developed a CNS relapse. Mild treatment-related white matter changes were observed in only 2 patients after consolidation therapy with three 5 g/m2 pulses of intravenous methotrexate. Transient enlargement of the ventricles and cortical sulci was observed in 13 patients, always temporally related to steroid treatment. These preliminary data suggest that treatment-related white matter changes are rare and no routine MRI follow-up is needed during treatment in asymptomatic children after a baseline assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miller DR (1980) Acute lymphoblastic leukemia. Pediatr Clin North Am 27: 269–291

    Google Scholar 

  2. Price RA, Jamieson PA (1975) The central nervous system in childhood teukemia. II. Subacute leukoencephalopathy. Cancer 35:306–318

    Google Scholar 

  3. Price RA, Birdwell DA (1978) The central nevous system in childhood leukemia. III. Mineralizing microangiopathy and dystrophic calcification. Cancer 42:717–728

    Google Scholar 

  4. Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, Di Chiro G (1978) Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298:815–818

    Google Scholar 

  5. Ochs JJ, Parvey LS, Whitaker JN, Bowman WP, Ch'ien L, Campbell M, Coburn T (1983) Serial cranial computedtomography scans in children with leukemia given two different forms of central nervous system therapy. J Clin Oncol 1:793–798

    Google Scholar 

  6. Chessels JM, Cox TCS, Kendall B, Cavanagh NPC, Jannoun L, Richards S (1990) Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular intramuscular methotrexate and two doses of radiation. Arch Dis Child 65:416–422

    Google Scholar 

  7. Vainionpää L, Laitinen J, Lanning M (1992) Cranial computed tomographic findings in children with newly diagnosed acute lymphoblastic leukemia: a prospective follow-up study during treatment. Med Pediatr Oncol 20:273–278

    Google Scholar 

  8. Pääkkö E, Vainionpää L, Lanning M, Laitinen J, Pyhtinen J (1992) White matter changes in children treated for acute lymphoblastic leukemia. Cancer 70:2728–2733

    Google Scholar 

  9. Packer RJ, Zimmerman RA, Bilaniuk LT (1986) Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 58:635–640

    Google Scholar 

  10. Asato R., Akiyama Y, Ito M, Kubota M, Okumura R, Miki Y, Konishi J, Mikawa H (1992) Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 70: 1997–2004

    Google Scholar 

  11. Wilson DA, Nitschke R, Bowman ME, Chaffin MJ, Sexauer CL, Prince JR (1991) Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiences. Radiology 180: 205–209

    Google Scholar 

  12. Gustafsson G, Berglund G, Garwicz S, Hertz H, Jonmundsson G, Moe PJ, Salmi TT, Seip M, Siimes MA, Yssing M (1989) A population-based study of children with standard risk acute lymphoblastic leukemia in the five Nordic countries. Acta Paediatr Scand 78:104–109

    Google Scholar 

  13. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollman B, Henze G (1986) Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Pädiatr 199:151–160

    Google Scholar 

  14. Wollner N, Burchenal JH, Lieberman PH, Exelby P, D'Angio G, Murphy ML (1976) Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer 37:123–134

    Google Scholar 

  15. Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA (1993) High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR 14:1014–1016

    Google Scholar 

  16. Valk PE, Dillon WP (1991) Radiation injury of the brain. AJNR 12:45–62

    Google Scholar 

  17. Walker RW, Allen JC, Rosen G, Caparros B (1986) Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 4:1845–1850

    Google Scholar 

  18. Borgna-Pignatti C, Battisti L, Marradi P, Balter R, Caudana R (1992) Transient neurologic disturbances in a child treated with moderate-dose methotrexate. Br J Haematol 81:448

    Google Scholar 

  19. Komatsu K, Takada G, Uemura K, Shishido F, Kanno I (1990) Decrease in cerebral metabolic rate of glucose after high-dose methotrexate in childhood acute lymphocytic leukemia. Pediatr Neurol 6:303–306

    Google Scholar 

  20. Ebner F, Ranner G, Slavc I, Urban Ch, Kleinert R, Radner H, Einspieler R, Justich E (1989) MR findings in methotrexate-induced CNS abnormalities. AJNR 10:959–964

    Google Scholar 

  21. Salinsky MC, Levine RL, Aubuchon JP, Schutta HS (1983) Acute cerebellar dysfunction with high-dose ARA-C therapy. Cancer 51:426–429

    Google Scholar 

  22. Herzig RH, Lazarus HM, Herzig GP, Coccia PF, Wolff SN (1985) Central nervous system toxicity with high-dose cytosine arabinoside. Semin Oncol 12: 233–236

    Google Scholar 

  23. Gay CT, Bodensteiner JB, Nitschke R, Sexauer C, Wilson D (1989) Reversible treatment-related leukoencephalopathy. J Child Neurol 4:207–212

    Google Scholar 

  24. Bentson J, Reza M, Winter J, Wilson G (1978) Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 2:16–23

    Google Scholar 

  25. Riccardi R, Brouwers P, Di Chiro G, Poplack DG (1985) Abnormal computed tomography brain scans in children with acute lymphoblastic leukemia: serial long-term follow-up. J Clin Oncol 3:12–18

    Google Scholar 

  26. Ochs J, Mulhern RK (1988) Late effects of antileukemic treatment. Pediatr Clin North Am 35:815–833

    Google Scholar 

  27. Pääkkö E, Talvensaari K, Pyhtinen J, Lanning M (1994) Decreased pituitary gland height after radiation treatment to the hypothalamic-pituitary axis evaluated by MR. AJNR 15:537–541

    Google Scholar 

  28. Pääkkö E, Talvensaari K, Pyhtinen J, Lanning M (1994) Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 36: 652–655

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pääkkö, E., Vainionpää, L., Pyhtinen, J. et al. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia. Neuroradiology 38, 264–268 (1996). https://doi.org/10.1007/BF00596544

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00596544

Key words

Navigation